Mustang Bio
MBIO
25 hedge funds and large institutions have $207K invested in Mustang Bio in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
0% less ownership
Funds ownership: 0.05% → 0.05% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
11% less funds holding
Funds holding: 28 → 25 (-3)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
44% less capital invested
Capital invested by funds: $373K → $207K (-$165K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$37.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.9K |
| 4 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$13.2K |
| 5 |
JPWM
Jamison Private Wealth Management
Milton,
Georgia
|
+$4.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$62.2K |
| 2 |
TFS
Thoroughbred Financial Services
Brentwood,
Tennessee
|
-$25K |
| 3 |
Jane Street
New York
|
-$22.7K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$8.17K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.41K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Jane Street
New York
| – | -$22.7K | -960 | Closed |
|
|
XT
27
XTX Topco
George Town,
Cayman Islands
| – | -$8.17K | -345 | Closed |
|
|
CAL
28
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | -$1K | -21 | Closed |
|
29
Osaic Holdings
Scottsdale,
Arizona
| – | -$62 | -3 | Closed |
|
|
PCWA
30
Pacific Capital Wealth Advisors
Corona,
California
| – | -$3 | – | – |
|
31
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$165 | +10 | +333% |
|
MBIO Hedge Fund Activity: Q3 2024 in Review
25 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q3 2024, worth a combined $207K — down 44% from $373K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MBIO and 4 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $56.5K. The largest seller was UBS Group, cutting an estimated $62.2K.
- 25 institutional investors held Mustang Bio (MBIO) as of Q3 2024, down from 28 in Q2 2024.
- Funds reported $207K of Mustang Bio stock for Q3 2024, down 44% quarter-over-quarter.
- 4 funds opened new Mustang Bio positions in Q3 2024 and 6 closed out, a net change of -2 holders.
- The largest Mustang Bio buyer in Q3 2024 was Geode Capital Management, an estimated $56.5K added.
- The largest Mustang Bio seller in Q3 2024 was UBS Group, an estimated $62.2K sold.
Based on aggregated 13F filings for Q3 2024.